# Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-dk-21-501-limited-competition-revision-to-the-longitudinal-monitoring/  
Official notice: https://www.grants.gov/search-results-detail/332636

> National Institutes of Health offered grants of up to $1.5 million to colleges and universities. It expected to make one award worth $1.5 million in total. Applications closed on August 17, 2021.

| Field | Value |
|---|---|
| Opportunity number | RFA-DK-21-501 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | August 17, 2021 |
| Award ceiling | $1.5 million |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $1.5 million |
| Cost sharing | not required |
| Assistance Listings | 93.847 |

## Who can apply

- Public and State controlled institutions of higher education

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See FOA for full eligibility details.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites one application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for Type 1 Diabetes Acute Pancreatitis Consortium (T1DAPC). This 5-year longitudinal observational clinical study was originally funded in September 2020 and is currently in its planning phase. It will conduct a prospective longitudinal observational study of the occurrence of new onset diabetes during an acute pancreatitis (AP) episode or subsequently, with an emphasis on type 1 diabetes (T1D). The study is designed to gain insight into the incidence, clinical evolution, etiology, type and pathophysiology of the T1D and other forms of diabetes after AP. The DCC is involved in coordination and study design, including data and biosample acquisition and management and is responsible for distribution of funding to the clinical centers for participant costs. This supplement provides funding for the T1DAPC DCC to support longitudinal Magnetic Resonance Imaging (MRI) and other types of biomarker studies of enrolled participants.

## Questions people ask

### Is RFA-DK-21-501 still open?

No. It closed on August 17, 2021.

### Who can apply for Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)?

Closed August 17, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.5 million each. About $1.5 million in total for one award.

### Who has been funded under RFA-DK-21-501?

NIH RePORTER lists 1 project funded under RFA-DK-21-501 in fiscal 2022, at 1 institution.

### Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before?

The largest recipients over five fiscal years were Regents of the University of Michigan, The Trustees of the University of Pennsylvania, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 7,877 awards worth $9.6 billion in that time.